Japan’s Chugai Pharmaceutical, which operates satellite labs throughout Asia, has plans to invest $355 million by 2021, to ramp up and accelerate its research and development (R&D) capabilities in Singapore.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
